Cargando…
Gaps and roadmap of novel neuromodulation targets for treatment of gait in Parkinson’s disease
Gait issues in Parkinson’s disease (PD) are common and can be highly disabling. Although levodopa and deep brain stimulation (DBS) of the subthalamic nucleus and the globus pallidus internus have been established therapies for addressing the motor symptoms of PD, their effects on gait are less predi...
Autores principales: | Cury, Rubens Gisbert, Pavese, Nicola, Aziz, Tipu Z., Krauss, Joachim K., Moro, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752758/ https://www.ncbi.nlm.nih.gov/pubmed/35017551 http://dx.doi.org/10.1038/s41531-021-00276-6 |
Ejemplares similares
-
Neuromodulation for Intractable Pain
por: Green, Alexander L., et al.
Publicado: (2020) -
The Use of Neuromodulation for Symptom Management
por: Farrell, Sarah Marie, et al.
Publicado: (2019) -
Exoskeleton gait training with spinal cord neuromodulation
por: Ivanenko, Yury, et al.
Publicado: (2023) -
Psychosis and concurrent impulse control disorder in Parkinson's disease: A review based on a case report
por: Guedes, Bruno Fukelmann, et al.
Publicado: (2016) -
Alpha oscillations in the pedunculopontine nucleus correlate with gait performance in parkinsonism
por: Thevathasan, Wesley, et al.
Publicado: (2012)